Clinical trial
Thymus Dosimetric and Morphologic Predictors of Radiation-Induced Lymphopenia in Stage III NSCLC
NCT07564089 is registered in ClinicalTrials.gov with You Peimeng as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Thymus Dosimetric and Morphologic Predictors of Radiation-Induced Lymphopenia in Stage III NSCLC
- Lead sponsor
- You Peimeng
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 10, 2026
- Completion date
- February 28, 2028
- Enrollment
- 450 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
number of lymphocytes, radiation-induced lymphopenia, thymus dosimetric